Shilpa Medicare Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Mr. Suraj Kumar Innani, was filed 20 Oct 2022.
Shilpa Medicare Limited: what insiders have been doing
Shilpa Medicare Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). Between 23 October 2025 and 23 October 2026, 2 insiders published 2 filings.
Only sales appear on the open market, 1 sale in all totalling €39k, filed by 1 insider. At €39k, the sale published on 29 September 2026 by Alpesh Maheshkumar Dalal is the largest of the period.
With 2 filings in twelve months, the company is quieter than the median of 4 filings across the 1,892 companies we follow on the same exchange. Our records for Shilpa Medicare Limited go back to 2021, with 2 purchases and 6 sales on the open market in total.
Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -50.3%Entry ₹280.38 · Close at T+365 ₹139.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Shilpa Medicare Limited Strong Buy (bullish), based on 4 analysts. Average price target: ₹881.25.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 500,000 shares-ReleaseSEBI:f5d29311b26a65361a1e3b11d7b694c5e317bd7d
- 4,000 shares@ ₹1,050.00100.0% of flowEquityMarket SaleSEBI:8fb3bed75d422ba80045ee5709ff4d5207425f5c
- 100,000 shares@ ₹837.4477100.0% of flowEquity SharesSEBI:d8676693126eacffb11344df94db556640132c76
- 675,000 shares@ ₹117.259312.2% of flowEquity SharesSEBI:af9d4798381a364f4fcbf0b18663453ac4ba8f02
- 200,000 shares@ ₹858.00100.0% of flowEquity SharesSEBI:6719a143d09dc44182bab93570468faadb2276e3
- 1,000,000 shares@ ₹858.00100.0% of flowEquity SharesSEBI:b7940556e9f970e8f063cd614d771f54e173de16
- 200,000 shares@ ₹858.00100.0% of flowEquity SharesSEBI:086cdfae80c7ef91864691cb1432b771d48910a6
- 675,000 shares@ ₹858.0072.8% of flowEquity SharesSEBI:aebd6868e01ee3c7815aa1023b3303af9f2ac358
- 675,000 shares@ ₹858.00100.0% of flowEquity SharesSEBI:8395aff071c0b9b4cdc82aa23a20ef9bee14f9ed
- 50,000 shares@ ₹760.8077100.0% of flowEquity SharesSEBI:47312a8610103a1ab744d2ea91dd16b43b45a1a9
- 10,000 shares@ ₹700.03100.0% of flowEquity SharesSEBI:bbd48f3533cfc99128dc1a7d47c953657f39b17a
- 44 shares@ ₹8.3636100.0% of flowEquity SharesSEBI:adcdaecb281b9ebab4aab6b343c5ddc0603260da
- 200,000 shares@ ₹308.158.2% of flowEquity SharesSEBI:56ebab6f5ba4068c02f393e51eba2fce2a911f95
- 400,000 shares@ ₹362.2019.0% of flowEquity SharesSEBI:9374ad2ebbb6a2569c7900a846e2c7c0ff9276cd
- 2,000,000 shares@ ₹346.00100.0% of flowEquity SharesSEBI:5b9291dbb6d2ccce1d8b0a63e7e273a22172aec7
- 1,500,000 shares@ ₹346.00100.0% of flowEquity SharesSEBI:6fa37dc5f2b303cdd112ded9056a5086f20288e6
- 1,500,000 shares@ ₹346.00100.0% of flowEquity SharesSEBI:84147673e7b03437754539e979cc6e290ece6fb8
- 1,500,000 shares@ ₹271.50100.0% of flowEquity SharesSEBI:5634afa9268e97e6c768a4bc1fc9e7627f195916
- 1,500,000 shares@ ₹271.65100.0% of flowEquity SharesSEBI:f527e32125fb476be1fc4172f90bfd04c5b66a52
- 2,000,000 shares@ ₹271.6587.8% of flowEquity SharesSEBI:68f81b8415c0d536642cb658aaac13a5c891ffd2
- 3,013 shares@ ₹335.766749.7% of flowEquity SharesSEBI:09bec50a417da19b9bc2d2bdcbb08c4f9bc99d2b
- 3,013 shares@ ₹339.879550.3% of flowEquity SharesSEBI:30632af516d2ef8835725ddda0cdd3eeb9aebe0fCanonical exit: 17 Jan 2023 (T+90)
- 1,000,000 shares100.0% of flowEquity SharesSEBI:cde3a23ebce8fec0aa8730e6f4dd070226dc7c47
- 1,000,000 shares100.0% of flowEquity SharesSEBI:b9105f962016cfe5265d7a81433dba6fab588eda
- 1,000,000 shares100.0% of flowEquity SharesSEBI:6d39f19120f2e12d4450ec2c15a8d5c9a4353403
25 of 28 declarations
About Shilpa Medicare Limited
Shilpa Medicare Limited is an Indian pharmaceutical company that specializes in the manufacturing of generic drugs and biopharmaceutical products. It focuses on the development of treatments for cancer and other complex diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
